Between 1943 and 1963, sulfadiazine was used successfully to abort outbreaks of meningococcal disease among military recruits. However, for the past several years, chemoprophylaxis with sulfadiazine has been ineffective because a high proportion of meningococci isolated now are resistant to the drug. It was logical, therefore, to search for another suitable agent for prophylaxis. Among the antibiotics used in the treatment of meningococcal disease, notably penicillin G, chloramphenicol, and tetracycline, all are uniformly ineffective in preventing infection. Several recent studies have shown that two new antimicrobial agents, rifampin and minocycline, have an effect on the nasopharyngeal carriage of meningococci which is similar to that of the sulfonamides (2, 3, 5) . However, it remains to be proved whether either of these agents can halt an established outbreak of meningococcal disease in a closed population.
Because the potential of rifampin for mass prophylaxis is limited by the rapid development of resistance by strains of Neisseria meningitidis (5) , minocycline was selected for further study. This report describes its use as a prophylactic agent during an outbreak of meningococcal disease at Fort Lewis, Wash., in the winter of 1971.
MATERIALS AND METHODS
Background. The United States Army Infantry Training Center at Fort Lewis has a daily complement of between 8,000 and 12,000 basic combat trainees. Upon their arrival at the training center, inductees are formed into companies of 150 to 250 men, and they remain in these units during their week of orientation and 8 weeks of training. Each company is rigidly segregated from all other training units, and during the first 4 weeks of training a recruit's only contact outside his company is through his training cadre, i.e., the 20 to 30 officers and men responsible for the training of each company.
Outbreaks of meningococcal disease have occurred among basic combat trainees during 4 To assess the effect of this effort at prophylaxis on the rate of carriage of meningococci, nasopharyngeal cultures were obtained from 350 men in their sixth week of training 2.5 and 4.5 weeks after the course of minocycine had been completed. In addition, the rate of meningococcal carriage among 217 trainees in a separate company (B-2-2) was determined before and at weekly intervals for 7 weeks after minocycline was given.
On 21 February, four weeks after the regimen of prophylaxis had been completed, an individual in his second week of training developed meningitis. Within the next 10 days, five additional cases of meningococcal disease occurred among the untreated recruits, which by this time consisted of 6,121 individuals and constituted 61% of all of the basic combat trainees. Beginning on 3 March, minocycline was administered to these men in a dosage of 100 mg every 12 hr. At the same time, a second course of minocycline, 200 mg in one daily dose for 3 days, was administered to recruits of company B-2-2 which was in its seventh week of training, to determine whether this regimen effectively reduced the rate of meningococcal carriage. This is the only company which received this simplified regimen and the only group to receive minocycline twice. On 8 March, the Surgeon General of the Army ordered the administration of the group C polysaccharide vaccine to all recruits in the first 6 weeks of basic training and to all inductees entering Fort Lewis through May 1971. Consequently, about 6,800 men received both minocycline and vaccine, and 2,100 men, who were in their seventh and eighth weeks of training on 8 March, were given neither vaccine nor additional minocycline for prophylaxis. Two of these men developed meningococcal meningitis 7 and 13 weeks after receiving the first course of minocycline. Both had graduated from basic combat training to advanced infantry training by the time they became ill. No subsequent cases of meningococcal disease were encountered at Fort Lewis through June 1971.
Laboratory procedures. All the cases of meningococcal disease described in this report were confirmed in the Department of Pathology of Madigan General Hospital, Fort Lewis, by isolation of group C meningococci from blood or cerebrospinal fluid. Nasopharyngeal cultures taken to determine rates of meningococcal carriage were obtained in the field according to procedures described previously (5) . Those acquired for routine surveillance were incubated locally for 24 hr in 5% CO2 at 37 C before being sent to the Sixth U.S. Army Area Laboratory where meningococci were identified and grouped serologically by standard techniques. Cultures obtained from company B-2-2 were processed in the laboratory of one of the authors (H.B.). All of the meningococci isolated from these cultures and 28% of those recovered in the Sixth Army Laboratory in January, February, and March were tested for susceptibility to minocycline and sulfadiazine by the agar-dilution method described previously (5) .
RESULTS
Effect of minocycline on the affack rate of meningococcal disease. In the 2 weeks prior to the first course of minocycline, five basic combat trainees developed meningococcal disease (Table  1) . Following prophylaxis, the number of men and the proportion of the total population of recruits who had received minocycline decreased progressively, because at the end of each week a battalion of recruits was graduated and was replaced by an untreated group entering training. New occurrences of meningitis were not encountered until almost 5 weeks after the first dose of minocycline was given and at a time when 50% of the recruits were untreated. After the second course of minocydline and institution of the vaccine program, no additional outbreaks of meningococcal disease occurred among basic combat trainees. The two men who developed meningitis Table 1 because they had graduated from basic training by the time they became ill.
Statistical analysis of these results was accomplished with calculations based on man-weeks and the assumption that the probability of meningococcal disease occurring was small and relatively constant for each man-week. The first of these assumptions is justified by the fact that, in the 15,030 man-weeks before prophylaxis, the epidemic incidence per 1,000 man-weeks was 0.333. The second assumption is difficult to prove, but is supported by the fact that the 12 recruits who developed meningococcal disease were in their first, second, third, sixth, seventh, and eighth week of training at the time they became ill.
Application of the epidemic attack rate of 0.333 per 1,000 man-weeks to the 18,886 man-weeks in the untreated group for weeks 0 through 5 (Table  1) leads to an expected number of cases of 6.3. There were in fact seven cases in this group during this period ( Table 2 ). In the treated group, 38,063 man-weeks were observed in weeks 0 through 5 with an expected number of cases of 12.7. However, no meningococcal disease occurred in this group, and the difference between the expected and observed occurrence was highly significant (P < 0.001). Data from weeks 6 through 8 were not used in these calculations because, shortly after the second course of minocycline, another prophylactic agent, the vaccine, was used.
When the same data are analyzed with the binomial test of the hypothesis that the treated and untreated group are different with respect to the occurrence of meningococcal disease, the results are similar. For on the carrier rate, because previous studies have shown that minocycline influences the carrier rate for only 4 to 5 weeks (5).
The rate of carriage of meningococci in the single company followed weekly after the first course of minocycline is shown in Fig. 2 . Treatment with antibiotics reduced the rate of carriage to about 4%, and by the fifth week of training it had risen only to 12 %. Two weeks later, however, the rate of carriage had climbed to 556% and remained high despite the fact that these men received a second course of minocycline in a different dosage. a p = 0.10, determined from the ratio of the difference of the means to the standard error of the difference.
Susceptibility of meningococci to minocycline and sulfadiazine. The minimal inhibitory concentration (MIC) of sulfadiazine for 83% of 403 strains of meningococcus isolated from nasopharyngeal carriers was 0.5 mg or more per 100 ml. The MIC of minocycline for 62 strains of meningococci isolated before the first course of treatment ranged from 0.06 to 1.0 ,ug/ml with a mean of 0.192 ,ug/ml. The mean and range of MIC for 341 isolates recovered after prophylaxis with minocycline were 0.22 and 0.03 to 0.50 ,g/ml, respectively, and did not differ significantly from the values obtained before treatment (Table  3) .
One hundred five isolates of meningococcus were recovered from 188 recruits in company B-2-2 3 days after they received their second course of prophylaxis. All of these strains were sensitive to 0.5 ,ug or less of minocycline per ml, and the mean MIC for the group was 0.25 Ag/ml.
Side effects and toxicity. Minocycline was well tolerated by the 14,800 recruits who received prophylaxis. Hypersensitivity reactions, consisting of rash or fever or both, necessitated discontinuing the drug in 0.14% of the men treated. About 7%O of the recruits had minor reactions consisting of headache, dizziness, or nausea. These were not sufficiently bothersome to require interruption of treatment. DISCUSSION The prophylactic administration of minocycline clearly influenced the course of this outbreak of meningococcal disease. The attack rate of meningitis among treated recruits and those who entered training after the first course of minocycline was zero for almost 5 weeks. The fact that new cases occurred when the proportion of untreated recruits in training reached 50% indicates that the conditions favoring the outbreak persisted, strengthening the argument that prophylaxis with minocycline provided protection for the men treated. Furthermore While it is likely that minocycline is less effective as a prophylactic agent than sulfadiazine, their relative value cannot be assessed from this study. Kuhns and co-workers concluded that the effectiveness of sulfadiazine in prophylaxis depended upon (i) treating all individuals in the group simultaneously, (ii) treating all persons who joined the group subsequent to initiation of prophylaxis before they were incorporated into the group, and (iii) keeping the treated group closed to reinfection from outside sources (6) . Two of these criteria for effective prophylaxis were not adhered to in this study, and, if minocycline is needed for prophylaxis in the future, each group entering training should receive drug before they begin the training cycle. It is possible that new cases would not have occurred within 5 weeks of the first course of minocycline if this prodedure had been followed.
Strains of N. meningitidis resistant to minocycline were not observed. However, if the drug is used for a long time in this setting, the possibility of resistant isolates occurring should be evaluated.
The ultimate control of the outbreak of meningococcal disease at Fort Lewis can probably be attributed to the use of the polysaccharide vaccine. This is the preferred method of preventing meningococcal disease, and, when an effective polyvalent vaccine becomes available, chemoprophylaxis on a large scale will be unnecessary. If, however, it is decided to administer the group C vaccine routinely throughout the military before vaccines against meningococci of groups A and B are ready for use, minocycline may be an important interim measure for controlling outbreaks due to sulfonamide-resistant organisms.
